Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children

[1]  G. Deschênes,et al.  Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients , 2013, European Journal of Clinical Pharmacology.

[2]  G. Deschênes,et al.  Limited Sampling Strategy for Estimating Individual Exposure of Tacrolimus in Pediatric Kidney Transplant Patients , 2011, Therapeutic drug monitoring.

[3]  F. Alvarez,et al.  Limited Sampling Strategies for Monitoring Tacrolimus in Pediatric Liver Transplant Recipients , 2011, Therapeutic drug monitoring.

[4]  Cees Neef,et al.  Optimal Sampling Strategy Development Methodology Using Maximum A Posteriori Bayesian Estimation , 2011, Therapeutic drug monitoring.

[5]  M. Fakhoury,et al.  Developmental Pharmacogenetics of Immunosuppressants in Pediatric Organ Transplantation , 2010, Therapeutic drug monitoring.

[6]  A. Prémaud,et al.  Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation , 2010, Clinical pharmacokinetics.

[7]  P. Marquet,et al.  Pharmacokinetic Modeling and Development of Bayesian Estimators in Kidney Transplant Patients Receiving the Tacrolimus Once-Daily Formulation , 2010, Therapeutic drug monitoring.

[8]  A. Bensman,et al.  Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients , 2009, Clinical pharmacology and therapeutics.

[9]  M. First.  First Clinical Experience With the New Once-Daily Formulation of Tacrolimus , 2008, Therapeutic drug monitoring.

[10]  J H Proost,et al.  Validation of limited sampling models (LSM) for estimating AUC in therapeutic drug monitoring--is a separate validation group required? , 2007, International journal of clinical pharmacology and therapeutics.

[11]  M. Pescovitz,et al.  Once‐Daily Tacrolimus Extended‐Release Formulation: 1‐Year Post‐Conversion in Stable Pediatric Liver Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Mary H. H. Ensom,et al.  Beyond Cyclosporine: A Systematic Review of Limited Sampling Strategies for Other Immunosuppressants , 2006, Therapeutic drug monitoring.

[13]  G. Filler,et al.  Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children , 2002, Pediatric transplantation.